To further assess the impact of PVT1 on pancreatic cancer sensitivity to gemcitabine in vivo, BALB/c nude mice bearing subcutaneous pancreatic xenograft tumors derived from PANC-1 cells stably expressing PVT1 were treated with 50 mg/kg gemcitabine. Here, PVT1 is linked to pancreatitis.